Dose escalation of ibandronate in patients with multiple myeloma and end-stage renal disease – an open label study

Bone ◽  
2006 ◽  
Vol 38 (3) ◽  
pp. 74
Author(s):  
D. Henrich ◽  
R. Bergner ◽  
M. Hoffmann ◽  
M. Uppenkamp
Keyword(s):  
Multiple Myeloma ◽  
Renal Disease ◽  
Dose Escalation ◽  
End Stage Renal Disease ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Stage Renal Disease ◽  
End Stage

Tolerability of Dose Escalation of Ibandronate in Patients with Multiple Myeloma and End-Stage Renal Disease: A Case Series

Onkologie ◽  
2009 ◽  
Vol 32 (8-9) ◽  
pp. 482-486 ◽  
Author(s):  
Dirk M. Henrich ◽  
Martin Hoffmann ◽  
Michael Uppenkamp ◽  
Raoul Bergner
Keyword(s):  
Multiple Myeloma ◽  
Renal Disease ◽  
Dose Escalation ◽  
End Stage Renal Disease ◽  
Case Series ◽  
Stage Renal Disease ◽  
End Stage

A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease

2017 ◽  
Vol 32 (1) ◽  
pp. e13155 ◽  
Author(s):  
Bassam G. Abu Jawdeh ◽  
Ervin Steve Woodle ◽  
Abbie D. Leino ◽  
Paul Brailey ◽  
Simon Tremblay ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Open Label ◽  
Phase Ib ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease

2019 ◽  
Vol 103 (11) ◽  
pp. 2366-2372 ◽  
Author(s):  
Thomas R. Spitzer ◽  
Nina Tolkoff-Rubin ◽  
A. Benedict Cosimi ◽  
Steven McAfee ◽  
Bimalangshu R. Dey ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Bone Marrow ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Leukocyte Antigen ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document